EnerSyn Global vs DataMeds AI
ESYN and MEDS side by side, both in wholesale trade-non-durable goods. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ESYN and MEDS compare
EnerSyn Global is the larger company, worth 4.6 times as much as DataMeds AI ($9.0M against $2.0M).
EnerSyn Global grew revenue faster over the last twelve months (−68.5% versus −77.5% for DataMeds AI).
DataMeds AI keeps more of each dollar of sales as profit, with a net margin of −565% compared with −680% at EnerSyn Global.
EnerSyn Global scores higher on the StockData Score (6 against 1 for DataMeds AI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ESYN | MEDS |
|---|---|---|
| Size and price | ||
| Market cap | $9.0M | $2.0M |
| Share price | $1.17 | $0.640 |
| Change, 1 year | −32.4% | −98.0% |
| Beta (5Y) | 0.10 | 0.34 |
| Employees | 4 | 35 |
| StockData Score | ||
| Total score | 6 (better) | 1 |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 23.2× | 0.3× (better) |
| P/B | 3.3× | – |
| FCF yield | −10.6% | – |
| Growth | ||
| Revenue growth (TTM) | −68.5% (better) | −77.5% |
| Profitability | ||
| Gross margin | 59.2% (better) | −92.1% |
| Operating margin | – | −548% |
| Net margin | −680% | −565% (better) |
| FCF margin | −245% | – |
| Return on equity | −88.9% (better) | −1707% |
| Return on invested capital | – | −153% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −6.2× |
| Current ratio | 1.82 (better) | 0.14 |
| Altman Z-score | 0.70 (better) | −8.90 |
| Piotroski F-score | 4 (better) | 1 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 1.1% | 1.7% |
| Insider net buying, 12 months | $402K | – |
Go deeper
- ESYN stock overview
- ESYN income statement
- ESYN valuation and score
- MEDS stock overview
- MEDS income statement
- MEDS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.